Medscape

SPIDER study makes the case for new distal-protection device

Washington, DC - In a study making the case for a new embolic-protection device, a trial of more than 700 patients with saphenous vein graft (SVG) disease has shown that the new SpideRX ...
TCTMD

TCT 999: Carotid angioplasty done with a Distal protection device(Spider FX) in a tortuous internal carotid artery with “Snake Hunt Technique”

TCT 1002: Shock And Awe: Shockwave Intravascular Lithotripsy and Stenting of a Complex Calcified Infrarenal Aortic Stenosis in a Symptomatic Elderly Patient Receive the the latest news, research, and ...
Medscape

Discordant results from DEAR-MI and PREMIAR: Future of embolic-protection devices seems dim

Paris, France - Results from two new studies have further muddled the debate over the value of distal protection/thrombectomy during PCI for STEMI. DEAR-MI, one of two trials presented during last ...
Yahoo Finance

U.S. Embolic Protection Devices Market and Competition Analysis, 2025-2033, Featuring Abbott Laboratories, Allium Medical Solutions, Boston Scientific, Cardinal Health and More

United States Embolic Protection Device Market is expected to reach US$ 650 million by 2033 from US$ 360 million in 2024, with a CAGR of 6.96% from 2025 to 2033. Rising cardiovascular operations, ...